Mibavademab

DB16673InvestigationalProtein Based Therapies

Mibavademab is under investigation in clinical trial NCT04159415 (Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy).

Mechanism: Pharmacologically active on Leptin receptor
Curator reviewed
Code names: REGN-4461

Resolves to

Compound

UNIIPHL2UDY3ABCAS2305770-44-7

Targets

P48357LEPR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mibavademab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account